Valuation: TransMedics Group, Inc.

Market Cap 2.85B 2.47B 2.33B 2.11B 3.97B 273B 3.99B 27.83B 10.72B 139B 10.7B 10.47B 440B P/E 2026 *
59x
P/E 2027 * 37.4x
Enterprise Value 2.81B 2.43B 2.3B 2.08B 3.91B 269B 3.94B 27.44B 10.57B 137B 10.55B 10.32B 434B EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.09x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day+4.48%
1 week-2.73%
Current month+1.17%
1 month-3.07%
3 months+13.75%
6 months-31.15%
Current year-29.42%
1 week 79.23
Extreme 79.23
89.55
1 month 79.23
Extreme 79.23
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 A Don

Chairman

-18,000 0.0528%
7/10/26 A Free

Chief Financial Officer

43,399 0.1273%
7/10/26 A Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
+4.48%-2.73%-24.88%+45.21% 2.85B
+0.62%+1.76%+29.33%+19.00% 225B
+1.55%-0.96%+7.80%-19.82% 141B
+2.38%+7.93%-12.92%+24.43% 130B
+4.82%+0.16%-54.89%-14.87% 62.29B
+1.99%-0.03%-18.12%-12.87% 49.39B
+1.36%-1.38%+12.45%+15.54% 48.63B
-0.09%-0.03%+16.85%+27.79% 41.42B
+0.41%+1.76%+37.11%+50.73% 40.12B
+2.16%+0.88%-17.77%+51.04% 31.23B
Average +1.89%-3.77%-2.50%+18.62% 77.25B
Weighted average by Cap. +1.53%-2.42%+5.02%+11.37%

Financials

2026 *2027 *
Net sales 742M 643M 607M 550M 1.03B 71.09B 1.04B 7.24B 2.79B 36.06B 2.79B 2.72B 115B 875M 758M 715M 649M 1.22B 83.84B 1.23B 8.54B 3.29B 42.53B 3.29B 3.21B 135B
Net income 51.99M 45.05M 42.51M 38.57M 72.35M 4.98B 72.87M 508M 196M 2.53B 195M 191M 8.04B 89.08M 77.19M 72.84M 66.08M 124M 8.54B 125M 870M 335M 4.33B 335M 327M 13.77B
Net Debt -40.26M -34.88M -32.92M -29.87M -56.02M -3.86B -56.43M -393M -152M -1.96B -151M -148M -6.22B -146M -126M -119M -108M -203M -13.96B -204M -1.42B -548M -7.08B -547M -535M -22.51B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
14/09/26 $85.86 +4.48% 942,829
11/09/26 $82.18 -3.36% 1,247,318
10/09/26 $85.04 -1.57% 591,859
09/09/26 $86.40 -2.12% 665,155
08/09/26 $88.27 -1.90% 594,550
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
82.18USD
Average target price
97.30USD
Spread / Average Target
+18.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!